07:00 , Sep 18, 2006 |  BC Week In Review  |  Company News

Akubio sales and marketing update

Akubio launched its RAP-id 4 biomolecular interactions analysis system. The system uses Akubio's Resonant Acoustic Profiling (RAP) technology to provide binding data for purified proteins and for proteins in complex mixtures. Akubio Ltd., Cambridge, U.K....
07:00 , Jun 19, 2006 |  BC Week In Review  |  Company News

Akubio management update

Akubio Ltd., Cambridge, U.K.   Business: Diagnostic   Hired: Andrew Mackintosh as CEO, formerly CEO of Oxford Instruments plc   ...
07:00 , Jun 19, 2006 |  BC Week In Review  |  Company News

Akubio board of directors update

Akubio Ltd., Cambridge, U.K.   Business: Diagnostic   Transition: Andrew Carr to non-executive from executive chairman   ...
08:00 , Mar 14, 2005 |  BC Week In Review  |  Company News

Akubio board of directors update

Akubio Ltd., Cambridge, U.K.   Business: Diagnostic   Appointed: Andrew Carr, former CEO of Amersham plc's Amersham Biosciences unit, as chairman; he replaces John Padfield, who departed   ...
07:00 , Jun 23, 2003 |  BC Week In Review  |  Company News

Akubio board of directors update

Akubio Ltd., Cambridge, U.K.   Business: Diagnostics/Imaging   Appointed: Petri Vainio, former general partner of Sierra Ventures   ...
07:00 , May 5, 2003 |  BC Week In Review  |  Company News

Akubio board of directors update

Akubio Ltd., Cambridge, U.K.   Business: Diagnostics/Imaging   Appointed: John Padfield, former CEO of Chiroscience Group plc, as chairman   ...
07:00 , Sep 9, 2002 |  BC Week In Review  |  Company News

Akubio management update

Akubio Ltd., Cambridge, U.K.   Business: Diagnostics/Imaging   Hired: John Pritchard as CEO, formerly VP of R&D in the diagnostics products unit at Genzyme Corp.   ...
07:00 , Sep 3, 2002 |  BC Extra  |  Company News

Akubio hires Pritchard as CEO

Diagnostics play Akubio (Cambridge, U.K.) appointed John Pritchard as CEO. Pritchard was formerly VP of R&D in the diagnostics products unit at Genzyme Corp. Akubio develops acoustic technology to detect infectious diseases and analyze molecular...
07:00 , Aug 26, 2002 |  BioCentury  |  Finance

Bioventures III biotech investments

Bioventures III biotech investments Year Company Amount raised 2002 BioImage $13.4M Galapagos Genomics $18.5M Hydra BioSciences $9.3M Xcounter $21.5M PicoLiter $22.0M 2001 Akubio $1.8M Astex Technology $8.3M Chroma Therapeutics $2.2M Guava Technologies $23.5M Inpharmatica $44.2M...
08:00 , Dec 10, 2001 |  BioCentury  |  Finance

Stocking stuffers

Pre-holiday fundraisers look to be having a jolly time, as debt and equity deals topped $1.6 billion in the first week of December. And in keeping with the season, some companies - much like most...